Does prostate cancer family history have an impact on active surveillance adherence in men with low- or favourable intermediate risk disease?

被引:0
|
作者
Leni, R. [1 ]
Stabile, A. [1 ]
Gandaglia, G. [1 ]
Mazzone, E. [1 ]
Cucchiara, V [1 ]
Bandini, M. [1 ]
Pellegrino, A. [1 ]
De Angelis, M. [1 ]
Quarta, L. [1 ]
Zaurito, P. [1 ]
Robesti, D. [1 ]
Fossati, N. [2 ]
Brembilla, G. [3 ]
Zaffuto, E. [4 ]
Deho, F. [4 ]
De Cobelli, F. [3 ]
Montorsi, F. [1 ]
Briganti, A. [1 ]
机构
[1] Univ Vita Salute San Raffaele, Dept Urol, IRCCS Osped San Raffaele, Milan, Italy
[2] Univ Svizzera Italiana, Dept Urol, Ente Osped Cantonale, Lugano, Switzerland
[3] Univ Vita Salute San Raffaele, Dept Radiol, IRCCS Osped San Raffaele, Milan, Italy
[4] Osped Circolo & Macchi Fdn, Dept Urol, Varese, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A0953
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Change in a 17-gene genomic prostate score over time in men with low- and intermediate-risk prostate cancer managed with active surveillance.
    Leapman, Michael S.
    Cowan, Janet E.
    Nguyen, Hao Gia
    Cooperberg, Matthew R.
    Carroll, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [32] Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study
    Rakauskas, Arnas
    Tawadros, Thomas
    Lucca, Ilaria
    Herrera, Fernanda
    Bourhis, Jean
    Burruni, Rodolfo
    Gomes, Maria Natal
    Codeluppi, Caroline
    Jolliet, Laura
    La Rosa, Stefano
    Meuwly, Jean Yves
    Jichlinski, Patrice
    Berthold, Dominik
    Valerio, Massimo
    INVESTIGATIVE AND CLINICAL UROLOGY, 2021, 62 (04) : 416 - 422
  • [33] Influence of Active Surveillance on Gleason Score Upgrade and Prognosis in Low- and Favorable Intermediate-Risk Prostate Cancer
    Hu, Xuanhan
    Miao, Jia
    Huang, Jiaqing
    Qian, Lin
    Zhang, Dahong
    Wei, Haibin
    CURRENT ONCOLOGY, 2022, 29 (10) : 7964 - 7978
  • [34] Active Surveillance for Black Men With Low-Risk Prostate Cancer
    Shen, Xinglei
    Pettaway, Curtis A.
    Chen, Ronald C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17): : 1733 - 1734
  • [35] Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance
    Whalen, Michael J.
    Pak, Jamie S.
    Lascano, Danny
    Ahlborn, David
    Matulay, Justin T.
    McKiernan, James M.
    Benson, Mitchell C.
    Wenske, Sven
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E425 - E435
  • [36] THE QUALITY OF ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER
    Levy, Mya E.
    Meyers, Stephanie
    Wood, David P.
    Montie, James E.
    Miller, David C.
    Wei, John T.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 179 - 179
  • [37] Family History of Prostate Cancer in Men Being Followed by Active Surveillance Does Not Increase Risk of Being Diagnosed With High-grade Disease EDITORIAL COMMENT
    Thomas, Christian
    Thueroff, Joachim W.
    UROLOGY, 2015, 85 (04) : 746 - 746
  • [38] Prognostic Value of the Intermediate Risk Feature in Men with Favorable Intermediate Risk Prostate Cancer: Implications for Active Surveillance
    Sherer, M.
    Nelson, T. J.
    Courtney, P. T.
    Guram, K.
    De Moraes, G. Rodrigues
    Bagrodia, A.
    Rose, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E246 - E247
  • [39] AFRICAN AMERICAN MEN WITH LOW-RISK PROSTATE CANCER MAY HAVE INCREASED RISK OF PROGRESSION ON ACTIVE SURVEILLANCE
    Iremashvili, Viacheslav
    Soloway, Mark S.
    Rosenber, Daniel L.
    Manoharan, Murugesan
    JOURNAL OF UROLOGY, 2012, 187 (04): : E540 - E540
  • [40] Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance
    Pepe, Pietro
    Pepe, Ludovica
    Pennisi, Michele
    Fraggetta, Filippo
    IN VIVO, 2024, 38 (03): : 1300 - 1305